Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7110878 | 0.87 | F2 (0.60) | F2F10 | |
| SCHEMBL7110792 | 0.87 | F2 (0.65) | F2F10 | |
| SCHEMBL7110290 | 0.85 | F2 (0.63) | F2F10 | |
| SCHEMBL7108999 | 0.85 | F2 (0.58) | F2F10 | |
| SCHEMBL7113381 | 0.84 | F2 (0.57) | F2F10 | |
| SCHEMBL7112024 | 0.82 | F2 (0.73) | F2 | |
| SCHEMBL7110448 | 0.82 | F2 (0.54) | F2F10 | |
| SCHEMBL7108074 | 0.81 | F2 (0.54) | F2F10 | |
| SCHEMBL7108067 | 0.80 | F2 (0.54) | F2 | |
| SCHEMBL7111502 | 0.80 | F2 (0.56) | F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030158218-A1 | Thrombin inhibitors | NANTERMET PHILIPPE G (US) | 2003-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030158218-A1 | Thrombin inhibitors | F2, SERPINC1, TFPI | F2 1/4885F10 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.